Microbix Biosystems Inc. Signs Letters of Intent to License its Flu Vaccine Yield Enhancement Technology

December 14, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

TORONTO, Dec. 14 /CNW/ - Microbix Biosystems Inc. (TSX:MBX) has signed two Letters Of Intent with companies outside North America which are interested in licensing the VIRUSMAX(TM) technology on a non-exclusive basis.

Twitter
LinkedIn
Facebook
Email
Print

Alliances